Ventilators Market by Mobility (Intensive Care, Portable), Type, Mode (Volume, Pressure, Combined), Interface (Invasive, Non-invasive), End-User (Hospital, Clinic, Home Care, ACC, Emergency Medical Services), Region - Global Forecast to 2026
[267 Pages Report] The ventilators market is projected to reach USD 1.9 billion in 2026 from USD 1.4 billion in 2021, at a CAGR of 7.6% during the forecast period. A ventilator, breathing machine, or respirator is a machine that assists with breathing. It is mainly used in hospitals to treat chronic obstructive pulmonary disease (COPD), sleep apnea, acute lung injury, and hypoxemia. Over the years, the ventilators market has evolved significantly due to technological advancements, such as developing advanced portable ventilators and improvements in the sensor technologies used in ventilators. The increasing number of preterm births, rapid growth in the geriatric population, rising prevalence of respiratory diseases, rising number of ICU beds, and rising number of COVID-19 patients are expected to drive growth in the ventilators market during the forecast period. The emergence of home healthcare has opened new avenues for the ventilators market. Convenience and comfort in the home care environment, coupled with cost advantages, are the other major factors driving growth in the home healthcare market for ventilators.
To know about the assumptions considered for the study, Request for Free Sample Report
Covid-19 Impact on the Ventilators Market
One of the major equipment used to treat COVID-19 is a medical ventilator. The demand for medical ventilators has risen dramatically, pushing manufacturers to increase output by 30–50%. In 2019, it was projected that 77,000 new ventilators would be sufficient to meet the global demand. In April 2020, around 30,000 extra ventilators were required in New York City alone. Various large firms were competing to manufacture and deliver as many ventilators as possible around the world.
Initiatives of companies for meeting the increased demand for ventilators:
Koninklijke Philips N.V. (Netherlands)
Philips is one of the leading manufacturers of medical ventilators. On April 24, 2020, the company announced that it intends to increase the production of hospital ventilators to 4,000 units/week by Q3 2020. Also, the company launched its new Philips Respironics E30 ventilator with an instantaneous production of 15,000 units/week. Furthermore, to strengthen its supply chain, the company, with its manufacturing partners, expanded its hospital ventilator assembly lines.
Medtronic (Ireland)
On April 8, 2020, the company received approval for the use of PB560 in the US through the FDA’s EUA authority. Earlier, the company used to ship more than 300 ventilators per week. To combat the pandemic, it was expected to increase its production from 300 to 700 ventilators per week (this figure was expected to increase to 1,000 ventilators per week by the end of June 2020).
AgVa Healthcare (India)
AgVa introduced a toaster-size ventilator that costs around USD 2,000, whereas conventional ventilators cost more than USD 10,000. The company was expected to produce 40,000 units per month (up from 500 per month) and planned to increase it further to 160,000 units per month.
Ventilators Market Dynamics
Driver: High prevalence of respiratory diseases
According to the WHO, respiratory diseases account for more than 10% of all disability-adjusted life-years (DALYs), a metric that estimates the amount of active and productive life lost due to a condition. In this regard, respiratory diseases are second only to cardiovascular diseases (including stroke). Among the top 30 causes of death, COPD is 3rd; lower respiratory tract infection is 4th; tracheal, bronchial, and lung cancer is 6th; tuberculosis is 12th; and asthma is 28th. More than a billion people worldwide suffer from acute or chronic respiratory illnesses. As a result, the growth in the number of patients suffering from respiratory disorders is a major factor driving the demand for ventilators.
High prevalence of COPD and asthma
COPD and asthma are the most prevalent respiratory disorders across the globe. As per the WHO, COPD is the third-leading cause of death worldwide, causing 3.23 million deaths in 2019. More than 80% of these deaths have occurred in low- and middle-income countries. Over 380 million people globally are estimated to have COPD. The number of undiagnosed COPD patients is high in regions and countries such as China, India, Brazil, and Eastern Europe. The cost incurred by healthcare systems across the globe due to COPD is ~USD 50 billion annually.
Some of the major causes of COPD are long-term asthma and prolonged exposure to tobacco smoke, indoor & outdoor air pollution, and occupational fumes & dust. Other comorbid chronic conditions, including cardiovascular disease, musculoskeletal impairment, and diabetes mellitus, are related to COPD. These conditions may also impact the health status of patients, as well as interfere with COPD management.
According to the WHO, in 2019, about 262 million people were suffering, and 0.5 million people died from asthma. In asthma, morbidity and mortality still remain prominent issues, and disease normalization is not achieved by any treatment. By 2025, it is expected that 100 million more asthmatic patients will be registered globally. In the US, the condition affects 1 in every 12 people, and in Europe, there are nearly 10 million people over 45 years of age living with asthma. It is estimated that up to 1,000 people die as a result of asthma every day.
Both COPD and asthma result in the narrowing of respiratory paths, making breathing difficult. Owing to this, a large number of patients suffering from COPD and asthma require external ventilation and airway management. As a result, the growth in the number of patients suffering from COPD and asthma is expected to drive the demand for ventilators.
High prevalence of tobacco smoking
Smoking is the leading cause of COPD. According to the WHO, tobacco kills up to half of its users. Over 80% of the world's 1.3 billion tobacco users live in low- and middle-income countries. As per the CDC, cigarette smoking remains the leading cause of preventable disease, disability, and death in the US, accounting for over 480,000 deaths annually. Around 34.1 million adults in the US currently smoke cigarettes, and over 16 million Americans live with a smoking-related disease.
Opportunity: Development of non-invasive and microprocessor-controlled portable ventilators
Technological advances in microprocessor-controlled ventilation integrated with the complexity of new ventilator modes have provided multidisciplinary teams in healthcare organizations with various opportunities to improve the care of critically ill patients on ventilators. Advanced ventilators are also primed for any type of exigencies and have numerous checks and balances in place. Patient-specific parameters, such as air pressure, air volume, and flow speed, and general parameters, such as air leakage, mechanical failure, power failure, battery backups, oxygen tanks, and remote control, are all equipped with sensors and monitors.
New portable life support ventilators are lighter and smaller, providing invasive, noninvasive, and mouthpiece ventilation. The advanced ventilation technology combines responsive leak and circuit compensation and precision flow trigger controls to enable comfortable breathing and accurate therapy. In recent times, manufacturers have been developing wirelessly connected portable ventilators to have a meaningful impact on patient outcomes. By connecting to a cloud-based patient management application, the current Bluetooth-enabled devices turn medical-grade data into actionable information, delivering it directly to the mobile devices or desktops of care providers multiple times per day. This solution enables care teams to monitor patients remotely and proactively, allowing for fast and informed clinical decisions, including early intervention, which can help avoid unnecessary readmissions and lower the cost of care.
Challenge: Low awareness and a large population of undiagnosed & undertreated patients
Major respiratory diseases, such as asthma and COPD, are largely undiagnosed and undertreated. This is particularly significant in developing economies due to the lower awareness and unavailability of adequate resources to diagnose these diseases. According to the WHO, more than 90% of COPD deaths and 80% of asthma deaths occur in low- and middle-income countries. COPD develops slowly, and it is usually diagnosed in people aged over 40 years, which makes it difficult to control in the later stages of life. It is estimated that around 70% of COPD patients are undiagnosed due to a lack of awareness. Similar to COPD, asthma is also highly undiagnosed and undertreated in around 50% of asthmatics. The large untreated number of patients for respiratory diseases is further restricting the use of ventilators.
The intensive care ventilator holds the largest share in ventilators market by mobility, in the forecast period
The intensive care segment accounted for the largest share of the global market in 2020. The large share of the intensive care ventilators segment can be attributed to the rising number of intensive care beds equipped with ventilators. Increasing ICU admissions due to COVID-19 and re-admissions in developed countries, coupled with appropriate reimbursements, are also responsible for the large share of the ICU ventilators segment.
The adult/pediatric ventilators segment accounted for the largest share of the ventilators market in 2020.
The large share of the adult/pediatric ventilators segment can be attributed to the large adult population suffering from COVID-19, the growing incidence of chronic diseases such as COPD & asthma, the growing number of smokers, and the rising geriatric population.
The invasive ventilation segment accounted for the largest share of the global market in 2020. Growth in the invasive ventilation market can be attributed to the increasing severity in COVID-19 patients and the rising prevalence of respiratory diseases, neurological diseases, and sleeping disorders.
The combined-mode ventilation segment accounted for the largest share of the ventilators market in 2020.
The large share of this segment can be attributed to its advantages over conventional pressure-mode ventilation and volume-mode ventilation. The ability of combined-mode ventilation to provide both modes of ventilation makes it a desirable product in the ventilators market.
The hospitals & clinics segment is likely to dominate the global market during the forecast period is attributed to the financial capabilities of hospitals to purchase high-priced instruments and the availability of trained professionals to operate ventilators. Market growth is also driven by the rapidly increasing incidence of coronavirus disease. The COVID-19 outbreak has not only created pressure on healthcare resources but has also increased the number of hospital admissions.
North America accounted for the largest share of the global Ventilators market., by region in the forecast period.
North America dominated the Ventilators market in the forecast period. The rising geriatric population, growing number of smokers, high prevalence of respiratory diseases, increasing COVID-19 patient volumes, highly developed healthcare system, high healthcare expenditure, and major market players in the US are the key factors driving the global market in North America.
To know about the assumptions considered for the study, download the pdf brochure
Key Market Players
Key players in the Ventilators Market: Koninklijke Philips N.V. (Netherlands), ResMed (US), Medtronic (Ireland), Fisher & Paykel Healthcare Limited (New Zealand), Drägerwerk AG & CO. KGAA (Germany), Nihon Kohden Corporation (Japan), Getinge AB (Sweden), Asahi Kasei Corporation (Japan), Air Liquide (France), Vyaire Medical, Inc. (US), GE Healthcare (US), Hamilton Medical (Switzerland), Smiths Group plc (UK), Allied Healthcare Products, Inc. (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd, (China), aXcent Medical GmbH (Germany), Metran Co., Ltd (Japan), MAGNAMED (Brazil), Avasarala Technologies Ltd (India), Airon Corporation (Florida), TRITON Electronic Systems Ltd. (Russia), Bio-Med Devices, Inc. (US), Hill-Rom Holdings, Inc. (US), HEYER Medical AG (Germany), and Leistung Engineering Pvt. Ltd. (Argentina).
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
|
Report Metric |
Details |
|
Market Size available for years |
2019-2026 |
|
Base Year Considered |
2020 |
|
Forecast period |
2021-2026 |
|
Forecast Unit |
Value (USD) |
|
Segments covered |
Ventilators Market: |
|
Geographies covered |
|
|
Companies Covered |
Koninklijke Philips N.V. (Netherlands), ResMed (US), Medtronic (Ireland), Fisher & Paykel Healthcare Limited (New Zealand), Drägerwerk AG & CO. KGAA (Germany), Nihon Kohden Corporation (Japan), Getinge AB (Sweden), Asahi Kasei Corporation (Japan), Air Liquide (France), Vyaire Medical, Inc. (US), GE Healthcare (US), Hamilton Medical (Switzerland), Smiths Group plc (UK), Allied Healthcare Products, Inc. (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd, (China), aXcent Medical GmbH (Germany), Metran Co., Ltd (Japan), MAGNAMED (Brazil), Avasarala Technologies Ltd (India), Airon Corporation (Florida), TRITON Electronic Systems Ltd. (Russia), Bio-Med Devices, Inc. (US), Hill-Rom Holdings, Inc. (US), HEYER Medical AG (Germany), and Leistung Engineering Pvt. Ltd. (Argentina) |
The research report categorizes the global market into the following segments:
Ventilators Market, By Mobility
- Intensive care ventilators
- Portable/ transportable ventilators
Ventilators Market, By Type
- Adult/pediatric ventilators
- Neonatal/infant ventilators
Ventilators Market, By Interface
- Invasive ventilation segment
- Non-invasive ventilation
Ventilators Market, By Mode
- Combined-mode ventilation
- Volume- mode ventilation
- Pressure-mode ventilation
- Other ventilation modes
Ventilators Market, By End User
- Hospitals & clinics
- Home care settings
- Ambulatory care centers
- Emergency medical services
Ventilators Market, by Region
- North America North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- Rest of Asia Pacific (RoAPAC)
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America (ROLATM)
- Middle East & Africa
Recent Developments:
PRODUCT LAUNCHES
Month & Year |
APPROACH |
Product Type |
Product Name |
dESCRIPTION |
Company NAme |
|
October 2021 |
Product Launch |
Savina Ventilators |
Savina 300 NIV |
Savina 300 NIV offers safe, effective, and reliable non-invasive ventilation for acute and alternative care environments. |
Drägerwerk AG & Co. KGaA (Germany) |
|
August 2021 |
Product Launch |
Accessories |
AirSense 11 |
Next-generation PAP (positive airway pressure) device is designed to help people with sleep apnea start and stay on therapy to treat and manage obstructive sleep apnea. |
ResMed (US) |
|
May 2021 |
Product Launch |
Airway Monitoring System |
SonarMed |
The SonarMed Airway Monitoring System helps address a life-threatening risk to newborns treated with a mechanical ventilator: dislodged and occluded breathing tubes. |
Medtronic (Ireland) |
|
April 2021 |
Product Launch |
Software |
Auto SRM |
These are new software options for the Servo-u and Servo-n ventilators. |
Getinge AB (Sweden) |
|
April 2021 |
Product Launch |
Mechanical Ventilator |
Servo-u MR |
Servo-u MR ventilators are used for MRI rooms. |
Getinge AB (Sweden) |
DEALS
Month & Year |
APPROACH |
Company 1 |
Company 2 |
Description |
Deal Size |
|
October 2021 |
Partnership |
GE Healthcare (US) |
Apprise Health Insights (US) |
The companies together launched Oregon’s Statewide Capacity System to track 7,368 beds and approximately 800 ventilators across 60 hospitals. |
NA |
|
October 2021 |
Acquisition |
Air Liquide (France) |
Betamed Pharmaceutical Co (PVT) Ltd (Zimbabwe) |
Expertise in the monitoring and care of patients with severe pathologies |
NA |
|
September 2021 |
Acquisition |
ICU Medical, Inc. |
Smiths Group plc (UK) |
The combined companies will be a leading infusion therapy company with the addition of Smiths Medical syringe and ambulatory infusion devices, vascular access, and vital care products into ICU Medical. |
USD 2.5 billion |
|
June 2021 |
Partnership |
Vyaire Medical, Inc. (US) |
GenWorks Healthcare Limited (India) |
The partnership in India expands the company's footprint and provides greater accessibility to high-quality pulmonary screening, testing, and treatment. |
NA |
|
April 2021 |
Acquisition |
Drägerwerk AG & Co. KGaA (Germany) |
STIMIT AG (Switzerland) |
Dräger expands its expertise in the field of lung-protective ventilation. |
NA |
OTHER DEVELOPMENTS
|
MONTH & Year |
TYPE OF DEVELOPMENT |
COMPANY NAME |
DESCRIPTION |
|
August 2020 |
Expansion |
Fisher & Paykel Healthcare Limited (New Zealand) |
The company opened a new manufacturing facility in Mexico. |
|
July 2020 |
Expansion |
Fisher & Paykel Healthcare Limited (New Zealand) |
The company opened a new manufacturing facility in New Zealand. |
|
June 2021 |
Expansion |
Vyaire Medical Inc. (US) |
Vyaire Medical has expanded to provide greater access to high-quality pulmonary screening, testing, and treatment in India. |
|
April 2020 |
Expansion |
Hamilton Medical (Switzerland) |
The company established its production site in the US to meet the increasing demand for ventilators during the COVID-19 pandemic. |
|
March 2020 |
Expansion |
Smiths Group plc (UK) |
A 10,000/month increase in the production of life-saving Smiths Medical paraPAC lightweight and portable ventilators was done to support the UK government to expand its supply chain capability. |
Frequently Asked Questions (FAQ):
Which are the top industry players in the global ventilators market?
The top market players in the global Ventilators market include are Koninklijke Philips N.V. (Netherlands), ResMed (US), Medtronic (Ireland), Fisher & Paykel Healthcare Limited (New Zealand), Drägerwerk AG & CO. KGAA (Germany), Nihon Kohden Corporation (Japan), Getinge AB (Sweden), Asahi Kasei Corporation (Japan), Air Liquide (France), Vyaire Medical, Inc. (US), GE Healthcare (US), Hamilton Medical (Switzerland), Smiths Group plc (UK) and Allied Healthcare Products, Inc. (US).
Which are the segments that have been included in this report?
This report has the following main segments:
- In the Ventilators market:
- By Mobility
- By Type
- By Interface
- By Mode
- By End User
- By Region
Which geographical region is dominating in the Ventilators market?
The global Ventilators market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. In 2020, the North America dominated the global market in 2020. The rising geriatric population, growing number of smokers, high prevalence of respiratory diseases, increasing COVID-19 patient volumes, highly developed healthcare system, high healthcare expenditure, and major market players in the US are the key factors driving the global market in North America.
Which is the leading segment in the ventilators market, by Mobility?
The intensive care ventilator accounted for the largest share in the forecast year. The large share of the intensive care ventilators segment can be attributed to the rising number of intensive care beds equipped with ventilators. Increasing ICU admissions due to COVID-19 and re-admissions in developed countries, coupled with appropriate reimbursements, are also responsible for the large share of the ICU ventilators segment.
What is the current size of the global ventilators market?
The ventilators market is projected to reach USD 1.9 billion in 2026 from USD 1.4 billion in 2021, at a CAGR of 7.6% during the forecast period. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 32)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 VENTILATORS MARKET SEGMENTATION
FIGURE 2 GLOBAL MARKET, BY REGION
1.4 YEARS CONSIDERED
1.5 CURRENCY
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.6 LIMITATIONS
1.7 STAKEHOLDERS
1.8 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 38)
2.1 RESEARCH DATA
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 4 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (VENTILATORS MARKET)
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 8 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: KONINKLIJKE PHILIPS N.V.
FIGURE 10 SUPPLY-SIDE MARKET SIZE ESTIMATION: GLOBAL MARKET (2020)
FIGURE 11 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR THE VENTILATORS MARKET (2021–2026)
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 13 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 14 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 STUDY ASSUMPTIONS
2.6 LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: VENTILATORS MARKET
2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE GLOBAL MARKET
3 EXECUTIVE SUMMARY (Page No. - 54)
FIGURE 15 VENTILATORS MARKET, BY MOBILITY, 2021 VS. 2026 (USD MILLION)
FIGURE 16 GLOBAL MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 17 GLOBAL MARKET, BY INTERFACE, 2021 VS. 2026 (USD MILLION)
FIGURE 18 GLOBAL MARKET, BY MODE, 2021 VS. 2026 (USD MILLION)
FIGURE 19 GLOBAL MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 20 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL MARKET
4 PREMIUM INSIGHTS (Page No. - 58)
4.1 VENTILATORS MARKET OVERVIEW
FIGURE 21 COVID-19 PANDEMIC AND GROWTH IN THE PREVALENCE OF CHRONIC RESPIRATORY DISEASES ARE DRIVING THE GROWTH OF THE GLOBAL MARKET
4.2 ASIA PACIFIC: MARKET, BY MOBILITY & COUNTRY (2020)
FIGURE 22 INTENSIVE CARE VENTILATORS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC VENTILATORS MARKET IN 2020
4.3 GLOBAL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 23 CHINA TO REGISTER THE HIGHEST GROWTH IN THE GLOBAL MARKET DURING THE FORECAST PERIOD
4.4 GLOBAL MARKET: REGIONAL MIX
FIGURE 24 NORTH AMERICA WILL CONTINUE TO DOMINATE THE MARKET IN 2026
5 MARKET OVERVIEW (Page No. - 61)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 25 VENTILATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 High prevalence of respiratory diseases
5.2.1.1.1 High prevalence of COPD and asthma
5.2.1.1.2 High prevalence of tobacco smoking
TABLE 3 PREVALENCE AND DEATHS CAUSED DUE TO SMOKING
5.2.1.2 Rapid growth in the global geriatric population
FIGURE 26 GLOBAL GERIATRIC POPULATION, BY REGION
5.2.1.3 Government initiatives toward increasing the availability of ventilators amidst the COVID-19 pandemic
5.2.1.4 Increasing number of patients transferred to intensive care units
5.2.1.5 Outbreak of the COVID-19 pandemic
5.2.1.6 Growing preference for home-based oxygen therapy
5.2.2 RESTRAINTS
5.2.2.1 Dearth of skilled medical workers
5.2.2.2 Over purchase of ventilators in hospitals
5.2.2.3 Reimbursement concerns
5.2.3 OPPORTUNITIES
5.2.3.1 Development of non-invasive and microprocessor-controlled portable ventilators
5.2.3.2 Growth in healthcare spending
TABLE 4 TOTAL HEALTH EXPENDITURE PER CAPITA IN PURCHASING POWER PARITY (USD)
5.2.3.3 Cost advantages of home care services
5.2.3.4 Growth opportunities in emerging countries
5.2.4 CHALLENGES
5.2.4.1 Low awareness and a large population of undiagnosed & undertreated patients
5.2.4.2 Harmful effects of certain devices on neonates
6 INDUSTRY INSIGHTS (Page No. - 68)
6.1 TECHNOLOGY ANALYSIS
6.1.1 ARTIFICIAL INTELLIGENCE IN THE VENTILATORS MARKET
6.1.1.1 Introduction
6.1.1.2 The future of healthcare—Big Data and artificial intelligence
6.1.1.3 Knowledge-based systems for ventilation management
FIGURE 27 AI INTEGRATION INTO VENTILATORS
6.1.1.4 COVID-19 to drive the demand for artificial intelligence in ventilators
6.1.2 SENSOR TECHNOLOGIES IN VENTILATORS
6.1.2.1 Introduction
6.1.2.2 Flow sensors
6.1.2.3 Oxygen sensors
6.1.2.4 Pressure sensors
6.1.3 TECHNOLOGIES WITH HIGH-GROWTH POTENTIAL
6.1.3.1 E-Nose technology
6.1.3.2 MEMS technology
6.1.3.3 Electrochemical technology
6.1.3.4 Paramagnetic technology
6.1.3.5 Wireless gas sensor technology
6.2 INDUSTRY TRENDS
TABLE 5 MARKET CONSOLIDATION AND THE RISING DEMAND FOR PORTABLE VENTILATORS ARE THE MAJOR TRENDS IN THE MARKET
6.2.1 RISING DEMAND FOR ENHANCED PORTABLE AND COMPACT VENTILATORS
6.2.2 CONSOLIDATION OF THE MARKET
FIGURE 28 RECENT ACQUISITIONS IN THE MARKET
6.2.3 GROWING DEMAND FOR MULTIMODAL VENTILATORS
6.2.4 INCREASING ADOPTION OF NON-INVASIVE VENTILATION
6.2.5 NON-MEDICAL COMPANIES ENTERING THE MARKET TO CATER TO THE INCREASING DEMAND FOR VENTILATORS
6.3 FACTOR ANALYSIS
6.3.1 POPULATION SCENARIO
FIGURE 29 TOTAL POPULATION, BY COUNTRY/REGION
FIGURE 30 URBAN POPULATION, BY COUNTRY/REGION
FIGURE 31 GERIATRIC POPULATION (AGED ABOVE 65 YEARS)
6.3.2 HEALTHCARE EXPENDITURE
FIGURE 32 THE US ACCOUNTED FOR THE HIGHEST HEALTHCARE EXPENDITURE (% OF GDP)
6.3.3 TARGET POPULATION
FIGURE 33 COVID-19 POPULATION: TOTAL POPULATION VS. RECOVERED POPULATION
6.4 PRICING ANALYSIS
TABLE 6 AVERAGE SELLING PRICE OF VENTILATORS OFFERED BY TOP PLAYERS
6.5 VALUE CHAIN ANALYSIS
FIGURE 34 VALUE CHAIN: VENTILATORS MARKET
6.6 ECOSYSTEM MAPPING
FIGURE 35 VENTILATORS MARKET: ECOSYSTEM ANALYSIS
6.7 SUPPLY CHAIN ANALYSIS
6.8 PORTER’S FIVE FORCES ANALYSIS
TABLE 7 PORTER’S FIVE FORCES ANALYSIS
6.8.1 THREAT OF NEW ENTRANTS
6.8.2 THREAT OF SUBSTITUTES
6.8.3 BARGAINING POWER OF SUPPLIERS
6.8.4 BARGAINING POWER OF BUYERS
6.8.5 INTENSITY OF COMPETITIVE RIVALRY
6.9 REGULATORY ANALYSIS
6.9.1 NORTH AMERICA
6.9.1.1 US
6.9.1.2 Canada
6.9.2 EUROPE
6.9.3 ASIA PACIFIC
6.9.3.1 Japan
6.9.3.2 China
6.9.3.3 India
6.10 PATENT ANALYSIS
6.10.1 PATENT PUBLICATION TRENDS FOR VENTILATORS
FIGURE 37 GLOBAL PATENT PUBLICATION TRENDS IN THE VENTILATORS MARKET, 2015–2020
6.10.2 TOP APPLICANTS (COMPANIES) OF VENTILATOR PATENTS
FIGURE 38 TOP COMPANIES THAT APPLIED FOR VENTILATOR PATENTS, 2015–2020
6.10.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE VENTILATORS MARKET
FIGURE 39 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR VENTILATOR PATENTS, 2015–2020
6.11 TRADE ANALYSIS
TABLE 8 VENTILATOR EXPORT AND IMPORT DATA, BY COUNTRY
6.12 CASE STUDY ANALYSIS
TABLE 9 REPLACEMENT PATTERN OF VENTILATORS: DEVELOPED ECONOMIES VS. DEVELOPING ECONOMIES
TABLE 10 VOLUME DATA OF VENTILATORS, ICU VENTILATORS, PORTABLE VENTILATORS, PAP DEVICES, CPAP DEVICES, BIPAP DEVICES, AND SPIROMETERS
6.13 IMPACT OF COVID-19 ON THE VENTILATORS MARKET
7 VENTILATORS MARKET, BY MOBILITY (Page No. - 92)
7.1 INTRODUCTION
TABLE 11 VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION)
7.2 INTENSIVE CARE VENTILATORS
TABLE 12 MAJOR PRODUCTS: ICU VENTILATORS
TABLE 13 INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 14 INTENSIVE CARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 15 INTENSIVE CARE MARKET, BY COUNTRY, 2019–2026 (UNITS)
7.2.1 HIGH-END ICU VENTILATORS
7.2.1.1 Improving healthcare infrastructure and rising healthcare expenditure in developing countries to drive market growth
TABLE 16 HIGH-END ICU VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 17 HIGH-END ICU MARKET, BY COUNTRY, 2019–2026 (UNITS)
7.2.2 MID-END ICU VENTILATORS
7.2.2.1 Mid-end ICU ventilators are in high demand owing to the COVID-19 pandemic
TABLE 18 MID-END ICU VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 19 MID-END ICU MARKET, BY COUNTRY, 2019–2026 (UNITS)
7.2.3 BASIC ICU VENTILATORS
7.2.3.1 Basic ICU ventilators are equipped with minimal features as compared to high-end and mid-end ICU ventilators
TABLE 20 BASIC ICU VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 21 BASIC ICU MARKET, BY COUNTRY, 2019–2026 (UNITS)
7.3 PORTABLE/TRANSPORTABLE VENTILATORS
7.3.1 LOW WEIGHT AND ROBUST NATURE HAVE INCREASED THE DEMAND FOR PORTABLE/TRANSPORTABLE VENTILATORS
TABLE 22 MAJOR PRODUCTS: PORTABLE/TRANSPORTABLE VENTILATORS
TABLE 23 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 24 PORTABLE/TRANSPORTABLE MARKET, BY COUNTRY, 2019–2026 (UNITS)
8 VENTILATORS MARKET, BY TYPE (Page No. - 106)
8.1 INTRODUCTION
TABLE 25 VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
8.2 ADULT/PEDIATRIC VENTILATORS
8.2.1 INCREASING NUMBER OF COVID-19 CASES AMONG ADULTS DRIVING THE DEMAND FOR ADULT VENTILATORS
TABLE 26 ADULT/PEDIATRIC VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
8.3 NEONATAL/INFANT VENTILATORS
8.3.1 NEW TECHNOLOGIES AND INNOVATIONS IN THE FIELD OF NEONATAL VENTILATORS TO DRIVE MARKET GROWTH
TABLE 27 NEONATAL/INFANT VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
9 VENTILATORS MARKET, BY INTERFACE (Page No. - 110)
9.1 INTRODUCTION
TABLE 28 VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION)
9.2 INVASIVE VENTILATION
9.2.1 INCREASING CASES OF COVID-19 AND RISING PREVALENCE OF RESPIRATORY DISEASES TO SUPPORT MARKET GROWTH
TABLE 29 INVASIVE VENTILATION MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
9.3 NON-INVASIVE VENTILATION
9.3.1 INCREASING ADOPTION OF NON-INVASIVE VENTILATION AMONG END USERS TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
TABLE 30 NON-INVASIVE VENTILATION MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
10 VENTILATORS MARKET, BY END USER (Page No. - 114)
10.1 INTRODUCTION
TABLE 31 VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2 HOSPITALS & CLINICS
10.2.1 GROWING PATIENT VOLUMES DUE TO COVID-19 TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
TABLE 32 GLOBAL MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION)
10.3 AMBULATORY CARE CENTERS
10.3.1 GROWING NUMBER OF OUTPATIENT VISITS TO DRIVE GROWTH IN THIS END-USER SEGMENT
TABLE 33 GLOBAL MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2019–2026 (USD MILLION)
10.4 EMERGENCY MEDICAL SERVICES
10.4.1 HIGH INCIDENCE OF TRAUMA INJURIES TO DRIVE MARKET GROWTH IN THE COMING YEARS
TABLE 34 GLOBAL MARKET FOR EMERGENCY MEDICAL SERVICES, BY COUNTRY, 2019–2026 (USD MILLION)
10.5 HOME CARE SETTINGS
10.5.1 HOME CARE VENTILATORS ARE CONVENIENT AND CAN BE USED IN THE COMFORT OF THE PATIENT’S HOME—KEY FACTORS DRIVING MARKET GROWTH
TABLE 35 GLOBAL MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2019–2026 (USD MILLION)
11 VENTILATORS MARKET, BY REGION (Page No. - 121)
11.1 INTRODUCTION
FIGURE 40 CHINA TO REGISTER THE HIGHEST GROWTH RATE IN THE VENTILATORS MARKET DURING THE FORECAST PERIOD
TABLE 36 VENTILATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 41 NORTH AMERICA: VENTILATORS MARKET SNAPSHOT
TABLE 37 NORTH AMERICA: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 38 NORTH AMERICA: MARKET, BY MOBILITY, 2019–2026 (USD MILLION)
TABLE 39 NORTH AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 40 NORTH AMERICA: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 41 NORTH AMERICA: MARKET, BY INTERFACE, 2019–2026 (USD MILLION)
TABLE 42 NORTH AMERICA: MARKET, BY MODE, 2019–2026 (USD MILLION)
TABLE 43 NORTH AMERICA: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.2.1 US
11.2.1.1 The US dominated the North American ventilators market in 2020
TABLE 44 US: KEY MACROINDICATORS FOR THE VENTILATORS MARKET
TABLE 45 US: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION)
TABLE 46 US: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 47 US: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 48 US: MARKET, BY INTERFACE, 2019–2026 (USD MILLION)
TABLE 49 US: MARKET, BY MODE, 2019–2026 (USD MILLION)
TABLE 50 US: MARKET, BY END USER, 2019–2026 (USD MILLION)
11.2.2 CANADA
11.2.2.1 Increasing incidence of COPD is driving the adoption of ventilators in Canada
TABLE 51 CANADA: COPD AND ASTHMA STATISTICS (2019 VS. 2020)
TABLE 52 CANADA: KEY MACROINDICATORS FOR THE VENTILATORS MARKET
TABLE 53 CANADA: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION)
TABLE 54 CANADA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 55 CANADA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 56 CANADA: MARKET, BY INTERFACE, 2019–2026 (USD MILLION)
TABLE 57 CANADA: MARKET, BY MODE, 2019–2026 (USD MILLION)
TABLE 58 CANADA: MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3 EUROPE
FIGURE 42 EUROPE: VENTILATORS MARKET SNAPSHOT
TABLE 59 EUROPE: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 60 EUROPE: MARKET, BY MOBILITY, 2019–2026 (USD MILLION)
TABLE 61 EUROPE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 62 EUROPE: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 63 EUROPE: MARKET, BY INTERFACE, 2019–2026 (USD MILLION)
TABLE 64 EUROPE: MARKET, BY MODE, 2019–2026 (USD MILLION)
TABLE 65 EUROPE: MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.1 GERMANY
11.3.1.1 Germany dominated the ventilators market in Europe in 2019
TABLE 66 GERMANY: KEY MACROINDICATORS FOR THE VENTILATORS MARKET
TABLE 67 GERMANY: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION)
TABLE 68 GERMANY: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 69 GERMANY: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 70 GERMANY: MARKET, BY INTERFACE, 2019–2026 (USD MILLION)
TABLE 71 GERMANY: MARKET, BY MODE, 2019–2026 (USD MILLION)
TABLE 72 GERMANY: MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.2 FRANCE
11.3.2.1 The highly advanced and well-established healthcare system in France driving market growth
TABLE 73 FRANCE: KEY MACROINDICATORS FOR THE VENTILATORS MARKET
TABLE 74 FRANCE: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION)
TABLE 75 FRANCE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 76 FRANCE: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 77 FRANCE: MARKET, BY INTERFACE, 2019–2026 (USD MILLION)
TABLE 78 FRANCE: MARKET, BY MODE, 2019–2026 (USD MILLION)
TABLE 79 FRANCE: MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.3 UK
11.3.3.1 Increasing healthcare expenditure is driving the growth of the ventilators market in the country
TABLE 80 UK: KEY MACROINDICATORS FOR THE VENTILATORS MARKET
TABLE 81 UK: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION)
TABLE 82 UK: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 83 UK: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 84 UK: MARKET, BY INTERFACE, 2019–2026 (USD MILLION)
TABLE 85 UK: MARKET, BY MODE, 2019–2026 (USD MILLION)
TABLE 86 UK: MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.4 ITALY
11.3.4.1 Presence of a well-developed healthcare system in the country and rapid growth in the aging population to drive market growth
TABLE 87 ITALY: KEY MACROINDICATORS FOR THE VENTILATORS MARKET
TABLE 88 ITALY: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION)
TABLE 89 ITALY: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 90 ITALY: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 91 ITALY: MARKET, BY INTERFACE, 2019–2026 (USD MILLION)
TABLE 92 ITALY: MARKET, BY MODE, 2019–2026 (USD MILLION)
TABLE 93 ITALY: MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.5 SPAIN
11.3.5.1 Increasing geriatric population to drive market growth in Spain
TABLE 94 SPAIN: KEY MACROINDICATORS FOR THE VENTILATORS MARKET
TABLE 95 SPAIN: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION)
TABLE 96 SPAIN: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 97 SPAIN: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 98 SPAIN: MARKET, BY INTERFACE, 2019–2026 (USD MILLION)
TABLE 99 SPAIN: MARKET, BY MODE, 2019–2026 (USD MILLION)
TABLE 100 SPAIN: MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.6 NETHERLANDS
11.3.6.1 Increasing patient population to support market growth in the Netherlands
TABLE 101 NETHERLANDS: KEY MACROINDICATORS FOR THE VENTILATORS MARKET
TABLE 102 NETHERLANDS: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION)
TABLE 103 NETHERLANDS: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 104 NETHERLANDS: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 105 NETHERLANDS: MARKET, BY INTERFACE, 2019–2026 (USD MILLION)
TABLE 106 NETHERLANDS: MARKET, BY MODE, 2019–2026 (USD MILLION)
TABLE 107 NETHERLANDS: MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.7 REST OF EUROPE
TABLE 108 ROE: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION)
TABLE 109 ROE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 110 ROE: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 111 ROE: MARKET, BY INTERFACE, 2019–2026 (USD MILLION)
TABLE 112 ROE: MARKET, BY MODE, 2019–2026 (USD MILLION)
TABLE 113 ROE: MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4 ASIA PACIFIC
FIGURE 43 ASIA PACIFIC: VENTILATORS MARKET SNAPSHOT
TABLE 114 ASIA PACIFIC: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 115 ASIA PACIFIC: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION)
TABLE 116 ASIA PACIFIC: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 117 ASIA PACIFIC: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 118 ASIA PACIFIC: MARKET, BY INTERFACE, 2019–2026 (USD MILLION)
TABLE 119 ASIA PACIFIC: MARKET, BY MODE, 2019–2026 (USD MILLION)
TABLE 120 ASIA PACIFIC: MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.1 JAPAN
11.4.1.1 Japan’s established healthcare system to support market growth during the forecast period
TABLE 121 JAPAN: KEY MACROINDICATORS FOR THE VENTILATORS MARKET
TABLE 122 JAPAN: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION)
TABLE 123 JAPAN: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 124 JAPAN: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 125 JAPAN: MARKET, BY INTERFACE, 2019–2026 (USD MILLION)
TABLE 126 JAPAN: MARKET, BY MODE, 2019–2026 (USD MILLION)
TABLE 127 JAPAN: MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.2 CHINA
11.4.2.1 Healthcare development and initiatives to curb COVID-19 to stimulate the market growth for ventilators in China
TABLE 128 CHINA: KEY MACROINDICATORS FOR THE VENTILATORS MARKET
TABLE 129 CHINA: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION)
TABLE 130 CHINA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 131 CHINA: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 132 CHINA: MARKET, BY INTERFACE, 2019–2026 (USD MILLION)
TABLE 133 CHINA: MARKET, BY MODE, 2019–2026 (USD MILLION)
TABLE 134 CHINA: MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.3 INDIA
11.4.3.1 Increasing COVID-19 patient volume to drive the ventilators market in India
TABLE 135 INDIA: KEY MACROINDICATORS FOR THE VENTILATORS MARKET
TABLE 136 INDIA: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION)
TABLE 137 INDIA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 138 INDIA: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 139 INDIA: MARKET, BY INTERFACE, 2019–2026 (USD MILLION)
TABLE 140 INDIA: MARKET, BY MODE, 2019–2026 (USD MILLION)
TABLE 141 INDIA: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.4 AUSTRALIA
11.4.4.1 High prevalence of chronic diseases to drive the demand for ventilators in Australia during the forecast period
TABLE 142 AUSTRALIA: KEY MACROINDICATORS FOR THE VENTILATORS MARKET
TABLE 143 AUSTRALIA: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION)
TABLE 144 AUSTRALIA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 145 AUSTRALIA: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 146 AUSTRALIA: MARKET, BY INTERFACE, 2019–2026 (USD MILLION)
TABLE 147 AUSTRALIA: MARKET, BY MODE, 2019–2026 (USD MILLION)
TABLE 148 AUSTRALIA: MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.5 REST OF ASIA PACIFIC
TABLE 149 ROAPAC: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION)
TABLE 150 ROAPAC: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 151 ROAPAC: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 152 ROAPAC: MARKET, BY INTERFACE, 2019–2026 (USD MILLION)
TABLE 153 ROAPAC: MARKET, BY MODE, 2019–2026 (USD MILLION)
TABLE 154 ROAPAC: MARKET, BY END USER,2019–2026 (USD MILLION)
11.5 LATIN AMERICA
TABLE 155 LATIN AMERICA: VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 156 LATIN AMERICA: MARKET, BY MOBILITY, 2019–2026 (USD MILLION)
TABLE 157 LATIN AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 158 LATIN AMERICA: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 159 LATIN AMERICA: MARKET, BY INTERFACE, 2019–2026 (USD MILLION)
TABLE 160 LATIN AMERICA: MARKET, BY MODE, 2019–2026 (USD MILLION)
TABLE 161 LATIN AMERICA: MARKET, BY END USER, 2019–2026 (USD MILLION)
11.5.1 BRAZIL
11.5.1.1 Healthcare infrastructure improvement to support market growth in Brazil
TABLE 162 BRAZIL: KEY MACROINDICATORS FOR THE VENTILATORS MARKET
TABLE 163 BRAZIL: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION)
TABLE 164 BRAZIL: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 165 BRAZIL: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 166 BRAZIL: MARKET, BY INTERFACE, 82019–2026 (USD MILLION)
TABLE 167 BRAZIL: MARKET, BY MODE, 2019–2026 (USD MILLION)
TABLE 168 BRAZIL: MARKET, BY END USER, 2019–2026 (USD MILLION)
11.5.2 MEXICO
11.5.2.1 Rising obesity rate to increase the incidence rate of respiratory diseases in Mexico
TABLE 169 MEXICO: KEY MACROINDICATORS FOR THE VENTILATORS MARKET
TABLE 170 MEXICO: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION)
TABLE 171 MEXICO: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 172 MEXICO: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 173 MEXICO: MARKET, BY INTERFACE, 2019–2026 (USD MILLION)
TABLE 174 MEXICO: MARKET, BY MODE, 2019–2026 (USD MILLION)
TABLE 175 MEXICO: MARKET, BY END USER, 2019–2026 (USD MILLION)
11.5.3 ARGENTINA
11.5.3.1 Rising prevalence of respiratory diseases in Argentina to drive market growth
TABLE 176 ARGENTINA: KEY MACROINDICATORS FOR THE VENTILATORS MARKET
TABLE 177 ARGENTINA: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION)
TABLE 178 ARGENTINA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 179 ARGENTINA: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 180 ARGENTINA: MARKET, BY INTERFACE, 2019–2026 (USD MILLION)
TABLE 181 ARGENTINA: MARKET, BY MODE, 2019–2026 (USD MILLION)
TABLE 182 ARGENTINA: MARKET, BY END USER, 2019–2026 (USD MILLION)
11.5.4 REST OF LATIN AMERICA
TABLE 183 ROLATAM: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION)
TABLE 184 ROLATAM: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 185 ROLATAM: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 186 ROLATAM: MARKET, BY INTERFACE, 2019–2026 (USD MILLION)
TABLE 187 ROLATAM: MARKET, BY MODE, 2019–2026 (USD MILLION)
TABLE 188 ROLATAM: MARKET, BY END USER, 2019–2026 (USD MILLION)
11.6 MIDDLE EAST & AFRICA
11.6.1 GROWING GERIATRIC POPULATION TO DRIVE GROWTH IN THE MIDDLE EAST & AFRICA
TABLE 189 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION)
TABLE 190 MIDDLE EAST & AFRICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 191 MIDDLE EAST & AFRICA: MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 192 MIDDLE EAST & AFRICA: MARKET, BY INTERFACE, 2019–2026 (USD MILLION)
TABLE 193 MIDDLE EAST & AFRICA: MARKET, BY MODE, 2019–2026 (USD MILLION)
TABLE 194 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2019–2026 (USD MILLION)
12 COMPETITIVE LANDSCAPE (Page No. - 191)
12.1 INTRODUCTION
TABLE 195 KEY MARKET DEVELOPMENTS (JANUARY 2018 TO JANUARY 2022)
12.2 REVENUE ANALYSIS OF KEY MARKET PLAYERS
FIGURE 44 REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN VENTILATORS MARKET
12.3 MARKET SHARE ANALYSIS
FIGURE 45 VENTILATORS MARKET SHARE, BY KEY PLAYER, 2020
12.4 COMPETITIVE SCENARIO
12.4.1 PRODUCT LAUNCHES
TABLE 196 GLOBAL MARKET: SERVICE LAUNCHES (JANUARY 2018 TO JANUARY 2022)
12.4.2 DEALS
TABLE 197 VENTILATORS MARKET: DEALS (JANUARY 2018 TO JANUARY 2022)
12.4.3 OTHER DEVELOPMENTS
TABLE 198 GLOBAL MARKET: OTHER DEVELOPMENTS (JANUARY 2018 TO JANUARY 2022)
12.5 COMPETITIVE BENCHMARKING
12.5.1 FOOTPRINT OF KEY PLAYERS IN THE VENTILATORS MARKET
12.5.2 MOBILITY FOOTPRINT OF COMPANIES
12.5.3 TYPE FOOTPRINT OF COMPANIES
12.5.4 INTERFACE FOOTPRINT OF COMPANIES
12.5.5 MODE FOOTPRINT OF COMPANIES
12.5.6 END-USER FOOTPRINT OF COMPANIES
12.5.7 REGIONAL FOOTPRINT OF COMPANIES
FIGURE 46 GEOGRAPHICAL ASSESSMENT OF MAJOR PLAYERS IN VENTILATORS MARKET
12.6 VENTILATORS MARKET: R&D EXPENDITURE
FIGURE 47 R&D EXPENDITURE OF KEY PLAYERS IN THE GLOBAL MARKET (2019 VS. 2020)
12.7 COMPANY EVALUATION MATRIX
12.7.1 STARS
12.7.2 EMERGING LEADERS
12.7.3 PERVASIVE PLAYERS
12.7.4 EMERGING COMPANIES
FIGURE 48 VENTILATORS MARKET: GLOBAL COMPANY EVALUATION MATRIX
12.8 COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS)
12.8.1 PROGRESSIVE COMPANIES
12.8.2 STARTING BLOCKS
12.8.3 RESPONSIVE COMPANIES
12.8.4 DYNAMIC COMPANIES
FIGURE 49 VENTILATORS MARKET: COMPANY EVALUATION MATRIX FOR SMES/START-UPS
13 COMPANY PROFILES (Page No. - 209)
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1 KEY PLAYERS
13.1.1 KONINKLIJKE PHILIPS N.V.
TABLE 199 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
FIGURE 50 COMPANY SNAPSHOT: KONINKLIJKE PHILIPS N.V. (2020)
13.1.2 RESMED
TABLE 200 RESMED INC.: BUSINESS OVERVIEW
FIGURE 51 COMPANY SNAPSHOT: RESMED (2020)
13.1.3 MEDTRONIC
TABLE 201 MEDTRONIC: BUSINESS OVERVIEW
FIGURE 52 COMPANY SNAPSHOT: MEDTRONIC (2020)
13.1.4 VYAIRE MEDICAL, INC.
TABLE 202 VYAIRE MEDICAL, INC.: BUSINESS OVERVIEW
13.1.5 GETINGE AB
TABLE 203 GETINGE AB: BUSINESS OVERVIEW
FIGURE 53 COMPANY SNAPSHOT: GETINGE AB (2020)
13.1.6 DRÄGERWERK AG & CO. KGAA
TABLE 204 DRÄGERWERK AG & CO. KGAA: BUSINESS OVERVIEW
FIGURE 54 COMPANY SNAPSHOT: DRÄGERWERK AG & CO. KGAA (2020)
13.1.7 SMITHS GROUP PLC
TABLE 205 SMITHS GROUP PLC: BUSINESS OVERVIEW
FIGURE 55 COMPANY SNAPSHOT: SMITHS GROUP PLC (2020)
13.1.8 HAMILTON MEDICAL
TABLE 206 HAMILTON MEDICAL: BUSINESS OVERVIEW
13.1.9 GE HEALTHCARE
TABLE 207 GE HEALTHCARE: BUSINESS OVERVIEW
FIGURE 56 COMPANY SNAPSHOT: GE HEALTHCARE (2020)
13.1.10 FISHER & PAYKEL HEALTHCARE LIMITED
TABLE 208 FISHER & PAYKEL HEALTHCARE LIMITED: BUSINESS OVERVIEW
FIGURE 57 COMPANY SNAPSHOT: FISHER & PAYKEL HEALTHCARE LIMITED (2020)
13.2 OTHER PLAYERS
13.2.1 AIR LIQUIDE
TABLE 209 AIR LIQUIDE: BUSINESS OVERVIEW
FIGURE 58 COMPANY SNAPSHOT: AIR LIQUIDE (2020)
13.2.2 ASAHI KASEI CORPORATION
TABLE 210 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW
FIGURE 59 COMPANY SNAPSHOT: ASAHI KASEI CORPORATION (2020)
13.2.3 ALLIED HEALTHCARE PRODUCTS, INC.
TABLE 211 ALLIED HEALTH PRODUCTS, INC.: BUSINESS OVERVIEW
FIGURE 60 COMPANY SNAPSHOT: ALLIED HEALTH PRODUCTS, INC. (2020)
13.2.4 NIHON KOHDEN CORPORATION
TABLE 212 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW
FIGURE 61 COMPANY SNAPSHOT: NIHON KOHDEN CORPORATION (2020)
13.2.5 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
13.2.6 AXCENT MEDICAL GMBH
13.2.7 METRAN CO., LTD.
13.2.8 MAGNAMED
13.2.9 LEISTUNG ENGINEERING PVT. LTD.
13.2.10 AVASARALA TECHNOLOGIES LIMITED
13.2.11 AIRON CORPORATION
13.2.12 TRITON ELECTRONIC SYSTEMS LTD.
13.2.13 HILL-ROM HOLDINGS, INC.
13.2.14 BIO-MED DEVICES, INC.
13.2.15 HEYER MEDICAL AG
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX (Page No. - 259)
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Business, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the ventilators market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The ventilators market comprises several stakeholders such as ventilator manufacturers and distributors and regulatory organizations. The demand side of this market is characterized by hospitals & clinics, home care setting, ambulatory care centres and emergency medical services.
Various primary sources from both, the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.
Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.
A breakdown of the primary respondents for ventilators market is provided below:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by mobility, by type, by interface, by mode, by end user, and region).
Data Triangulation
After arriving at the market size, the total ventilators market was divided into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments, data triangulation, and market breakdown procedures were employed, wherever applicable.
Objectives of the Study
- To define, describe, analyze, and forecast the size of the ventilators market on the basis of mobility, type, interface, mode, end user, and region.
- To provide detailed information on the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
- To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To forecast the size of the market segments with respect to North America, Europe, Asia Pacific, latin America and Middle East and Africa.
- To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies.
- To track and analyze competitive developments such as product launches, partnerships, acquisitions and other developments in the market.
- To benchmark players within the ventilators market using the Competitive Leadership Mapping framework which analyzes market players on various parameters within the broad categories of business and product strategy.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific ventilators market into South Korea, New Zealand, and other countries.
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
Growth opportunities and latent adjacency in Ventilators Market